Hepta and octapeptide agonists of protease-activated receptor 2

Journal of Peptide Science

Volumn 13, Issue 12, 2007, Pages 856-861

  Devlin, Mark G ^a   Pfeiffer, Bernhard ^b   Flanagan, Bernadine ^b   Beyer, Renée L ^b   Cocks, Thomas M ^a   Fairlie, David P ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

A549 cells; Agonist; Calcium fluorescence; Cancer; GPCR; Inflammation; PAR2; Protease activated receptor; SLIGKV; SLIGRL; Structure activity relationship

Indexed keywords

CALCIUM ION; CARBOXYL GROUP; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPTAPEPTIDE; OCTAPEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CHO CELL; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; VASCULAR RING;

ANIMALS; AORTA; CALCIUM; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MUSCLE, SMOOTH; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-2; STRUCTURE-ACTIVITY RELATIONSHIP;

CRICETULUS GRISEUS; RATTUS; RODENTIA;

EID: 37349086108     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.912     Document Type: Article

References (14)

1. Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD, Wallace JL, Morelli A, Cirino G. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc. Natl. Acad. Sci. U.S.A. 2001; 98: 13936-13941.
2. Cocks TM, Fong B, Chow JM, Anderson GP, Frauman AG, Goldie RG, Henry PJ, Carr MJ, Hamilton JR, Moffatt JD. A protective role for protease-activated receptors in the airways. Nature 1999; 398: 156-160.
3. Moffatt JD, Jeffrey KL, Cocks TM. Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice. Am. J. Respir. Cell Mol. Biol. 2002; 26: 680-684.
4. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L, Vergnolle N. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 2002; 161: 1903-1915.
5. Cenac N, Garcia-Villar R, Ferrier L, Larauche M, Vergnolle N, Bunnett NW, Coelho AM, Fioramonti J, Bueno L. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J. Immunol. 2003; 170: 4296-4300.
6. Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol. Sci. 2001; 22: 146-152.
7. Vergnolle N. Modulation of visceral pain and inflammation by protease-activated receptors. Br. J. Pharmacol. 2004; 141: 1264-1274.
8. Kelso EB, Lockhart JC, Hembrough T, Dunning L, Plevin R, Hollenberg MD, Sommerhoff CP, McLean JS, Ferrell WR. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J. Pharmacol. Exp. Ther. 2006; 316: 1017-1024.
9. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, Meek SE, Smith AJ, Hunter GD, McLean JS, McGarry F, Ramage R. Jiang L, Kanke T, Kawagoe J. Essential role for proteinase-activated receptor-2 in arthritis. J. Clin. Invest. 2003; 111: 35-41.
10. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol. Rev. 2004; 84: 579-621.
11. Maryanoff BE, Santulli RJ, McComsey DF, Hoekstra WJ, Hoey K, Smith CE, Addo M, Darrow AL, Andrade-Gordon P. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Arch. Biochem. Biophys. 2001; 386: 195-204.
12. Barry GD, Le GT, Fairlie DP. Agonists and antagonists of protease activated receptors (PARs). Curr. Med. Chem. 2006; 13: 243-265.
13. Kawabata A, Oono Y, Yonezawa D, Hiramatsu K, Inoi N, Sekiguchi F, Honjo M, Hirofuchi M, Kanke T, Ishiwata H. 2-Furoyl-LIGRL-NH2, a potent agonist for proteinase-activated receptor-2, as a gastric mucosal cytoprotective agent in mice. Br. J. Pharmacol. 2005; 144: 212-219.
14. Al-Ani B, Wijesuriya SJ, Hollenberg MD. Proteinase-activated receptor 2: differential activation of the receptor by tethered ligand and soluble peptide analogs. J. Pharmacol. Exp. Ther. 2002; 302: 1046-1054.